Search

everythinglearnresearchcommunity

for

Search:↓

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Cis-UCA can form new compounds without enzymes, and sulphide donors reduce its UVB-induced toxicity in skin cells.

The AAcQLI is a promising tool for assessing quality of life in children with alopecia areata.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

The new criteria for classifying lupus are more accurate and comprehensive.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

The revised Chinese Symptom Checklist-90 is more reliable and valid for psychological assessments.

Nearly half of the classification tools in the National Institute of Health and Clinical Excellence's Clinical Knowledge Summaries might not effectively guide management for general practitioners.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

WomenCare helps predict PCOD risk in women to encourage early medical consultation.

The authors agree they didn't follow the original criteria strictly but found the Ottawa rule effective in all tested patients and suggest it might have wider use.

The study aims to create a model to improve personalized and preventive health care.

The document suggests finding a simpler, cheaper way to diagnose Uncombable Hair Syndrome.

Personalized homeopathic treatment improved chronic spontaneous urticaria symptoms.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Both EQ-5D-5L and SF-6DV2 are valid for measuring health but can't be used interchangeably.

The new protocol using Cellutome™ and RCM safely assesses wound healing in detail.

New tools and criteria have been developed to better assess and treat pediatric lupus.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

A new tool helps lupus patients and doctors better track symptoms and quality of life.

A person got uncombable hair syndrome from two copies of chromosome 1 from their mother.

The updated criteria improve the accuracy of diagnosing lupus.

The new tool helps measure the impact of alopecia areata on children's quality of life.

The updated GRADE guidance advises considering context when interpreting variability in research results and introduces tools for assessing subgroup effects.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.